None
Conditions
Interventions
Peripheral vein group:Intravenously administered with fospropofol through the peripheral vein.
Central venous group:Intravenously administered with fospropofol through the central vein.
Sponsors
The Third People's Hospital of Yibin
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1)Patients scheduled for elective surgeries who require deep vein catheterization due to their medical conditions. (2)ASA I-III. (3)18 to 65 years old.
Exclusion criteria
Exclusion criteria: (1)The patient refused. (2)The patients who with contraindications for deep vein puncture, such as infection or burn at the puncture site, known thrombosis of the puncture vessel, occlusion of the puncture vessel, coagulation dysfunction, abnormal or variant anatomical structure, or when the patient is unable to cooperate. (3)Patients who are allergic to fospropofol. (4)Patients with skin diseases and abnormal skin sensations. (5)Patients with severe liver and kidney dysfunction. (6)Patients who participated in other interventional studies within three months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence rate of abnormal sensations; | — |
Secondary
| Measure | Time frame |
|---|---|
| The onset time of sedative effect;The incidence of hypotension;The degree of decrease in the lowest blood pressure (mean arterial pressure, MAP) during anesthesia induction; | — |
Countries
China
Contacts
Public ContactLi Xiong
The Third People's Hospital of Yibin
Outcome results
None listed